top of page
Untitled design (26)-1.webp

CROs Solutions

Gal3n helps Contract Research Organizations (CROs) to standardize remote monitoring and enhance site performance across their research network, ensuring regulatory readiness for hybrid and decentralized studies.

CROs.jpeg

Standardized Remote Monitoring and Enhanced Site Performance

By integrating Gal3n's platform (G-Pod and G-Cart units), CROs empower Principal Investigators (PIs) and Sub-Investigators to conduct full remote physical exams—including comprehensive specialty assessments (heart, lung, ear, skin)—using FDA-cleared peripherals. This deployment allows site coordinators to manage patient setup while PIs connect via the secure, compliant system. The result is a significant reduction in protocol deviations, real-time oversight of geographically distant sites, and improved patient retention by minimizing travel burdens for trial participants.

How Gal3n Transformed Decentralized Trials for Apex Clinical Research CRO

AdobeStock_1775680929-min.webp

Background:

Apex Clinical Research, a global CRO managing multiple decentralized studies, was facing operational bottlenecks. Many of its partner sites struggled with limited investigator availability, delayed physical exams, and challenges monitoring participants located in rural or remote areas. These inefficiencies led to study delays, missed data points, and rising operational costs.

Challenge:

Apex needed a solution that would enable Principal Investigators (PIs) to perform remote physical exams across multiple study locations while keeping all data compliant, accurate, and audit-ready for sponsors.

Solution:

Apex implemented the Gal3n platform, deploying G-Carts at core research sites and G-Pods for satellite and home visits. Using FDA-cleared diagnostic devices—including digital stethoscopes, otoscopes, dermatoscopes, and vitals monitors—PIs could perform complete physical exams remotely through Gal3n’s secure telehealth interface. Site nurses or coordinators assisted participants onsite while the PI joined live to listen to heart and lung sounds, inspect ears or skin, and review vitals in real time. All session data was automatically encrypted and uploaded into Apex’s eSource system, ensuring full 21 CFR Part 11 compliance and easy sponsor access for review.

Results:

• 40% fewer protocol deviations due to enhanced PI oversight


• 60% faster completion of required visits


• Higher sponsor satisfaction during remote and on-site audits


• Expanded recruitment by reaching participants in underserved regions

Conclusion:

With Gal3n, Apex Clinical Research modernized its decentralized trial operations—turning fragmented, delayed site workflows into a cohesive, compliant, and efficient remote examination model. The platform empowered investigators to stay engaged with patients anywhere in the world, ensuring cleaner data, improved retention, and accelerated study timelines across all research programs.

Let’s talk about the right solution for your team.

Fill out this form and we’ll connect with you to answer questions, provide next steps, and help you get started.

bottom of page